Sionna Therapeutics: NBD1 Stabilization Could Redefine Cystic Fibrosis Treatment

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
MusicRadar

“You'll come for the hands-on tweaking but stay for the sound”: Modal Electronics Carbon8X review

You'll come for the hands-on tweaking and wealth of features, and quickly forgive some of the workflow issues when you hear ...

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
eLife

Frequency-dependent modulation of foveal contrast sensitivity by fine-scale exogenously triggered attention

Fine-scale exogenous attention within the foveola selectively enhances contrast gain at low-to-mid spatial frequencies while increasing response gain across a broad spatial frequency range.
IEEE

Fast and Robust Modulation Classification via Kolmogorov-Smirnov Test

Abstract: A new approach to modulation classification based on the Kolmogorov-Smirnov (K-S) test is proposed. The K-S test is a non-parametric method to measure the goodness of fit. The basic ...
The Scientist

The Scientist - Home

Leaders at EBRAINS, a collection of tools and data resources for basic neuroscience research, are finalizing the platform’s 10-year plan amid calls to improve its usability.